FDA Drug Application (021883) for DALVANCE by DURATA THERAPS INTL

Back to FDA Applications sponsored by DURATA THERAPS INTL

Application Number021883
Product Number001
FormPOWDER;IV (INFUSION)
DosageEQ 500MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDALVANCE
Active IngredientDALBAVANCIN HYDROCHLORIDE



Back to FDA Applications sponsored by DURATA THERAPS INTL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.